Skip to content

Profound Medical PROF Change in receivables

Change in receivables at other companies

Cabot Corporation logo
Cabot CorporationCBT
-$64M-256%
Ryan Specialty Holdings logo
Ryan Specialty HoldingsRYAN
$77.8M+355%
Federated Hermes logo
Federated HermesFHI
$4.62M-57.8%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
-$18.13M
Sharplink, Inc.
 logo
Sharplink, Inc. SBET
-$273K-500%
US Physical Therapy logo
US Physical TherapyUSPH
$2.6M+435%

Other financials

Income statement

See full
Revenue$5.3M+104%
Gross profit$3.8M+107%
Operating income-$8.0M+28.2%
Net income-$7.1M+34.2%
EPS (diluted)$0.19-47.2%

Balance sheet

See full
Cash & equivalents$50.3M+8.3%
Total debt$7.5M+52.8%
Total equity$59.4M+17.0%
Total assets$73.5M+20.7%

Cash flow

See full
Operating cash flow-$8.6M-3.6%
CapEx$44.0K
Free cash flow-$9.6M

Valuation

See full
Market cap$241.65M+30.7%
Enterprise value$198.81M+28.7%
P/S12.8×-2.8×

Profitability

See full
Gross margin71.1%+3.4pp
Operating margin-202.6%-51.3pp
Net margin-206.8%-39.0pp
FCF margin-238.4%

Returns & leverage

See full
Return on equity-70.6%+4.8pp
Debt / equity0.1×0.0×
Current ratio6.6×-4.8×

Where this comes from

Reported directly by Profound Medical in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables.

The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Profound Medical's change in receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Profound Medical's change in receivables?
Profound Medical (PROF) reported change in receivables of $2.24M in Q1 2026.
How has Profound Medical's change in receivables changed year-over-year?
Profound Medical's change in receivables increased by 305.5% year-over-year, from -$1.09M to $2.24M.
What does change in receivables mean?
Change in total receivables including trade and non-trade receivables.